NDC 0409-1109

Atracurium Besylate

Atracurium Besylate

Atracurium Besylate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Atracurium Besylate.

Product ID0409-1109_041598c5-43e4-4d62-aab7-eb153c834b6a
NDC0409-1109
Product TypeHuman Prescription Drug
Proprietary NameAtracurium Besylate
Generic NameAtracurium Besylate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2013-02-25
Marketing CategoryANDA / ANDA
Application NumberANDA090782
Labeler NameHospira, Inc.
Substance NameATRACURIUM BESYLATE
Active Ingredient Strength10 mg/mL
Pharm ClassesNeuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0409-1109-01

10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1109-01) > 5 mL in 1 VIAL, SINGLE-DOSE (0409-1109-11)
Marketing Start Date2013-02-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-1109-11 [00409110911]

Atracurium Besylate INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA090782
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-11-13

NDC 0409-1109-01 [00409110901]

Atracurium Besylate INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA090782
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-02-25

Drug Details

Active Ingredients

IngredientStrength
ATRACURIUM BESYLATE10 mg/mL

OpenFDA Data

SPL SET ID:de1c2dcd-295b-47ce-b7a1-a8be59939a54
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 966768
  • 1718913

    • Pharmacological Class

    • Neuromuscular Nondepolarizing Blockade [PE]
    • Nondepolarizing Neuromuscular Blocker [EPC]

    NDC Crossover Matching brand name "Atracurium Besylate" or generic name "Atracurium Besylate"

    NDCBrand NameGeneric Name
    0409-1105Atracurium BesylateATRACURIUM BESYLATE
    0409-1109Atracurium BesylateATRACURIUM BESYLATE
    25021-659Atracurium Besylateatracurium besylate
    25021-672Atracurium Besylateatracurium besylate
    55150-216Atracurium BesylateAtracurium Besylate
    55150-217Atracurium BesylateAtracurium Besylate
    65862-984Atracurium BesylateAtracurium Besylate
    65862-985Atracurium BesylateAtracurium Besylate
    67457-698Atracurium Besylateatracurium besylate
    67457-699Atracurium Besylateatracurium besylate
    71288-701Atracurium BesylateAtracurium Besylate
    71288-702Atracurium BesylateAtracurium Besylate
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.